Amuvatinib

amuvatinib · Astex Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Amuvatinib, covering 2024-08-02 to 2024-08-02. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer [Phase 2]

See pricing